Published in J Neurol Neurosurg Psychiatry on April 28, 2006
Biology of intracranial aneurysms: role of inflammation. J Cereb Blood Flow Metab (2012) 1.73
Pathogenesis of intracranial aneurysm is mediated by proinflammatory cytokine TNFA and IFNG and through stochastic regulation of IL10 and TGFB1 by comorbid factors. J Neuroinflammation (2015) 1.44
TNF-alpha-mediated inflammation in cerebral aneurysms: a potential link to growth and rupture. Vasc Health Risk Manag (2008) 1.31
Molecular mechanisms of traumatic brain injury: the missing link in management. World J Emerg Surg (2009) 1.15
Genetic risk factors for intracranial aneurysms: a meta-analysis in more than 116,000 individuals. Neurology (2013) 0.96
Association between IL6 -174G/C and cancer: A meta-analysis of 105,482 individuals. Exp Ther Med (2012) 0.89
Population stratification in a case-control study of brain arteriovenous malformation in Latinos. Neuroepidemiology (2008) 0.89
Interactions of miR-34b/c and TP53 polymorphisms on the risk of intracranial aneurysm. Clin Dev Immunol (2012) 0.87
Distribution of the IL-1RN, IL-6, IL-10, INF-γ, and TNF-α Gene Polymorphisms in the Mexican Population. Genet Test Mol Biomarkers (2012) 0.80
Inflammation and human cerebral aneurysms: current and future treatment prospects. Future Neurol (2013) 0.78
Interleukin-6 (-636 c/g) gene polymorphism in korean children with kawasaki disease. Korean Circ J (2011) 0.77
Intracardiac Myxoma, Cerebral Aneurysms and Elevated Interleukin-6. Case Rep Neurol (2015) 0.75
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest (1998) 6.76
A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet (2004) 3.24
Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol (1997) 2.30
Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation (2001) 2.29
The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J (2001) 2.21
Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol (2001) 1.96
Origin, growth, and rupture of saccular aneurysms: a review. Neurosurgery (1981) 1.92
Mechanisms of perinatal brain injury. Semin Neonatol (2000) 1.43
Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab (2003) 1.38
Genesis of cerebral aneurysms--an update. Acta Neurochir (Wien) (2001) 1.37
Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage. Neurochem Res (1997) 1.24
Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease. Thromb Haemost (1996) 1.14
A -174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction. Neurosci Lett (2002) 1.11
Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Témoin de l'Infarctus du Myocarde. J Mol Med (Berl) (2001) 1.11
Cytokines as plasma markers of abdominal aortic aneurysm. Clin Chem Lab Med (2000) 1.11
Interleukin-6 and development of vasospasm after subarachnoid haemorrhage. Acta Neurochir (Wien) (1998) 1.09
The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population [corrected]. Neuroreport (2002) 1.04
Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res (1998) 1.03
Interleukin-6 mRNA expression by cortical neurons in culture: evidence for neuronal sources of interleukin-6 production in the brain. J Neuroimmunol (1995) 1.00
Cytokines predict coronary aneurysm formation in Kawasaki disease patients. Eur J Pediatr (1993) 0.97
Cytokine levels in cerebrospinal fluid and delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage. J Korean Med Sci (2001) 0.94
Evidence of admixture from haplotyping in an epidemiological study of UK Caucasian males: implications for association analyses. Hum Hered (2004) 0.89
-174 G/C interleukin-6 gene polymorphism and increased risk of multi-infarct dementia: a case-control study. Exp Gerontol (2002) 0.85
Dysregulation of immune response following neurosurgical operations. Acta Anaesthesiol Scand (2000) 0.83
2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans. Nature (1994) 21.30
Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA (1995) 20.12
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
Cigarette smoking by socioeconomic group, sex, and age: effects of price, income, and health publicity. BMJ (1994) 8.10
Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med (1992) 7.40
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol (1998) 7.26
THE EFFECTS OF PRESSOR DRUGS AND OF SALINE KIDNEY EXTRACTS ON BLOOD PRESSURE AND SKIN TEMPERATURE. J Clin Invest (1938) 5.60
Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study. BMJ (2001) 4.89
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis (2000) 4.88
Systematic review of water fluoridation. BMJ (2000) 4.18
New model for the secondary structure of the 5' non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. J Mol Biol (1989) 4.09
Complete nucleotide sequence of Saccharomyces cerevisiae chromosome VIII. Science (1994) 3.97
Names are key to the big new biology. Trends Ecol Evol (2010) 3.86
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Errors in the polymerase chain reaction. Nucleic Acids Res (1988) 3.52
Three-dimensional imaging by deconvolution microscopy. Methods (1999) 2.78
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation (2005) 2.77
Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol (1997) 2.73
Non-invasive assessment of lung elastance in patients with acute respiratory distress syndrome. Minerva Anestesiol (2014) 2.65
Sustained partnership in primary care. J Fam Pract (1996) 2.64
Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol (2003) 2.63
Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure. Lancet (1991) 2.55
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med (2006) 2.55
The psychological autopsy approach to studying suicide: a review of methodological issues. J Affect Disord (1998) 2.43
Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study. BMJ (2000) 2.40
Nicotine acts as a pharmacological chaperone to up-regulate human alpha4beta2 acetylcholine receptors. Mol Pharmacol (2005) 2.39
Electrophoresis for genotyping: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose. Anal Biochem (1994) 2.38
Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem (1996) 2.36
Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation (2001) 2.29
Relationship between static and dynamic foot postures in professional baseball players. J Orthop Sports Phys Ther (1999) 2.24
Use of Bartonella antigens for serologic diagnosis of cat-scratch disease at a national referral center. Arch Intern Med (1995) 2.15
The pharmacogenetics of chemical carcinogenesis. Pharmacogenetics (1992) 2.12
The Northwick Park Neck Pain Questionnaire, devised to measure neck pain and disability. Br J Rheumatol (1994) 2.11
Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database. Ann Hum Genet (2008) 2.05
The anaesthetist and the environment. Anaesthesia (2010) 2.01
Prevalence of Bartonella henselae antibodies in pet cats throughout regions of North America. J Infect Dis (1995) 2.00
Frustrations of fur-farmed mink. Nature (2001) 2.00
Antithrombin III and arterial disease. Lancet (1991) 1.98
Medical officers in industry. J Soc Occup Med (1975) 1.98
A pilot survey of decisions by acute medicine staff after thunderclap headache. J R Coll Physicians Edinb (2013) 1.98
Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol (2001) 1.96
Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway. J Thromb Haemost (2004) 1.91
Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor. Mol Cell Biol (1993) 1.91
Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat Med (1999) 1.86
Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet (1987) 1.85
Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J (2000) 1.83
Dissonance and the pill: an attribution approach to studying the arousal properties of dissonance. J Pers Soc Psychol (1974) 1.82
Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J Natl Cancer Inst (1998) 1.81
Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis. Health Technol Assess (2000) 1.80
Human gene for physical performance. Nature (1998) 1.78
Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector. J Gen Virol (1989) 1.77
Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk. J Med Genet (2006) 1.76
A comparison between co-trimoxazole and amoxycillin in the treatment of acute otitis media in general practice. Practitioner (1976) 1.74
Present and future possibilities for defining a phenotype for specific language impairment. J Speech Lang Hear Res (1999) 1.70
Relationship between markers of activated coagulation, their correlation with inflammation, and association with coronary heart disease (NPHSII). J Thromb Haemost (2007) 1.67
Bradykinin B2BKR receptor polymorphism and left-ventricular growth response. Lancet (2001) 1.67
Regulation of Btk by Src family tyrosine kinases. Mol Cell Biol (1996) 1.66
A common DNA polymorphism of the low-density lipoprotein (LDL) receptor gene and its use in diagnosis. Lancet (1985) 1.64
ICRP Publication 111 - Application of the Commission's recommendations to the protection of people living in long-term contaminated areas after a nuclear accident or a radiation emergency. Ann ICRP (2009) 1.63
Whistle blowers. BMJ (1992) 1.63
The Leyton obsessional inventory. Psychol Med (1970) 1.62
Randomized trial of informed consent and recruitment for clinical trials in the immediate preoperative period. Anesthesiology (1999) 1.62
The isolation of a clone for human alpha 1-antitrypsin and the detection of alpha 1-antitrypsin in mRNA from liver and leukocytes. Biochem Biophys Res Commun (1983) 1.62
Neurenteric cyst of the cerebellopontine angle: case report. Neurosurgery (1998) 1.62
A study of DNA polymorphisms around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals. Clin Genet (1985) 1.62
Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol (1985) (1999) 1.61
Shared characteristics of suicides and other unnatural deaths following non-fatal self-harm? A multicentre study of risk factors. Psychol Med (2011) 1.58
There are approximately 20 actin gene in the human genome. Nucleic Acids Res (1981) 1.58
Rapidly evolving myopathy with myosin-deficient muscle fibers. Ann Neurol (1994) 1.58
Risk of fatal stroke in patients with treated familial hypercholesterolemia: a prospective registry study. Stroke (2003) 1.57
Phosphotyrosine-containing proteins and expression of transformation parameters in cells infected with partial transformation mutants of Rous sarcoma virus. J Virol (1983) 1.56
Use of double-replacement gene targeting to replace the murine alpha-lactalbumin gene with its human counterpart in embryonic stem cells and mice. Mol Cell Biol (1994) 1.55
Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects. Diabetologia (2000) 1.54
Isolation and characterisation of a cDNA clone for human apolipoprotein CI and assignment of the gene to chromosome 19. Hum Genet (1985) 1.53
[Diabetic care in Norwegian general practice. A report of current status from Salten and some regions in Rogaland]. Tidsskr Nor Laegeforen (1997) 1.53
Urinary incontinence and depression. J Urol (1999) 1.51
Human alpha6 AChR subtypes: subunit composition, assembly, and pharmacological responses. Neuropharmacology (2000) 1.49
Letter: Clofibrate and gallstones. Lancet (1975) 1.49
Randomised clinical trial of the effectiveness of base-in prism reading glasses versus placebo reading glasses for symptomatic convergence insufficiency in children. Br J Ophthalmol (2005) 1.48
Proteus syndrome: an expanded phenotype. Am J Med Genet (1987) 1.47
New approaches to the study of cellulose biosynthesis. J Cell Sci Suppl (1985) 1.47
Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Circ Res (2002) 1.46
Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine (2000) 1.46
Chronic nicotine treatment up-regulates human alpha3 beta2 but not alpha3 beta4 acetylcholine receptors stably transfected in human embryonic kidney cells. J Biol Chem (1998) 1.45
Structural parameters of the vastus medialis muscle. Clin Anat (2005) 1.44
High altitude arrhythmias. Cardiology (2008) 1.42
Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J (1995) 1.41
Mysterious conditions. Br Dent J (2008) 1.40
Image-guided neurosurgery. Hosp Med (1999) 1.40
The ACE gene and muscle performance. Nature (2000) 1.40
The critical care research networks experience. Neurocrit Care (2012) 1.40
A low cost spacer device used for asthma treatment in a Calcutta street clinic to improve efficacy of metered dose inhalers. Trop Doct (1998) 1.39
A role for radiotherapy in the treatment of solid and papillary neoplasms of the pancreas. Cancer (1985) 1.39
Radiation cataractogenesis: a review of recent studies. Radiat Res (2009) 1.38
Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab (2003) 1.38
TennCare: Tennessee's Medicaid experiment. Health Aff (Millwood) (1996) 1.38
An integrative computational model for intestinal tissue renewal. Cell Prolif (2009) 1.36
Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol (2000) 1.36